Skip to content
Neogen Chemicals logo

Neogen Chemicals

NEOGEN NSE
₹2,273.60 +93.60 (+4.29%)
P/E
171.59
View as Markdown
MCP
Close 4 Nov 2026 ₹2,273.60 +818.20 +56.2% 1Y
Start ₹1,455.40

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
6.46%
Debt to Equity
1.71
EPS (TTM)
₹13.25
Book Value
₹525.10
Market Cap
—
P/E (TTM)
171.59
P/B
4.33
ROE
3.58%
Dividend Yield
0.05%
EBITDA
₹143 Cr
52W High
₹2,785.00
52W Low
₹966.70
Day Range
₹2,150.30 – ₹2,290.00
Volume
99,089

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Neogen Chemicals peer comparison
Pidilite Industries
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
Gujarat Fluorochemicals
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
Navin Fluorine International
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
Deepak Nitrite
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
Aether Industries
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
Aarti Industries
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
Atul
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
Neogen Chemicals (this company)
₹2,273.60171.59₹6,555 Cr4.330.05%3.58%6.46%₹926 Cr₹35 Cr
Median 8 companies₹1,926.0057.54₹20,474 Cr5.190.16%9.74%11.65%₹6,136 Cr₹692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

38 Weak

Data confidence 100/100

credit_downgrade

Category scores

Quality
24
Poor
Returns, margins, earnings quality 22% weight
Valuation
13
Poor
Cheap vs sector & own history 24% weight
Growth
61
Good
Sales & profit trajectory 9% weight
Financial Health
20
Poor
Solvency, leverage, coverage 9% weight
Momentum
86
Strong
Trend strength, vol-adjusted 12% weight
Ownership
63
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company's median sales growth is 20.3% of last 10 years
  • Company's working capital requirements have reduced from 112 days to 84.6 days

Weaknesses

7
  • Stock is trading at 7.47 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -4.69%
  • Company has a low return on equity of 4.90% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 13.6% of profits over last 3 years
  • Company has high debtors of 161 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallNeutral676
OscillatorsBearish270
Moving AveragesStrong Bullish406

Key readings

RSI (14)
48.42
Neutral
MACD (12,26,9)
−47.78
Bearish
SMA (50)
2,313.82
Bearish
SMA (200)
1,831.63
Bullish

As of

Analyst Rating

Based on 10 analysts
BUY70%

7 of 10 analysts rate Buy, 3 Hold, 0 Sell.

As of

BUY
7
70%
HOLD
3
30%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+24.04%
5Y+20.74%
3Y+7.91%
1Y+10.80%
TTM+18.11%

Net profit

Net profit growth by window
10Y+19.22%
5Y−1.32%
3Y−16.60%
1Y−17.14%
TTM+6.06%

Operating cash flow

Operating cash flow growth by window
10YTurned negative
5YTurned negative
3YOutflow widened by ₹201 Cr
1YTurned negative
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+1.89 pp
5Y−3.16 pp
3Y−0.44 pp
1Y−1.59 pp
TTM−0.97 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹110 Cr
Mar 2018₹161 Cr
Mar 2019₹239 Cr
Mar 2020₹306 Cr
Mar 2021₹336 Cr
Mar 2022₹487 Cr
Mar 2023₹686 Cr
Mar 2024₹691 Cr
Mar 2025₹778 Cr
Mar 2026₹862 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹8.00 Cr
Mar 2018₹11.00 Cr
Mar 2019₹21.00 Cr
Mar 2020₹29.00 Cr
Mar 2021₹31.00 Cr
Mar 2022₹45.00 Cr
Mar 2023₹50.00 Cr
Mar 2024₹36.00 Cr
Mar 2025₹35.00 Cr
Mar 2026₹29.00 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹216 Cr +50.6% vs FY26
Reported High Mean Low

AI News Digest

121d ago

TL;DR: Limited news flow for Neogen Chemicals this period. The promoter share pledge of 13.19 lakh shares is a mild governance concern worth monitoring, though not uncommon among mid-cap promoters. The upcoming analyst meet on Jun 23 could provide fresh catalysts or clarity on growth outlook. Overall, the newsflow is thin and the trend is neutral pending more operational or financial updates.

Headwinds 1
  • Promoter pledges 13.19 lakh shares Jun 17

    Dr. Harin Kanani pledged 13,19,083 equity shares on March 30, 2026, disclosed under SEBI takeover regulations. Promoter pledging can signal financial stress or margin requirements.

Neutral 1
  • Analyst meet scheduled Jun 23 Jun 12

    Neogen Chemicals management will participate in an analyst meeting on June 23, 2026, at Grand Hyatt, Mumbai, covering business overview and financial outlook.

Quarterly Results

₹ Cr
NEOGEN quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
165
162
164
200
180
193
201
203
187
209
220
247
250
296
Expenses
137
136
144
164
149
159
167
166
155
179
188
203
202
251
Operating Profit
28
26
20
36
31
35
35
36
32
30
32
44
48
45
OPM %
17%
16%
12%
18%
17%
18%
17%
18%
17%
14%
14%
18%
19%
15%
Other Income
2
2
2
2
2
1
1
−13
1
2
2
1
4
4
Interest
11
11
11
10
10
13
13
12
13
19
22
21
21
28
Depreciation
5
6
6
6
7
7
7
7
6
7
7
8
8
9
PBT
14
11
6
22
16
15
15
4
14
5
6
16
23
13
Tax %
28%
28%
81%
25%
27%
29%
34%
35%
28%
35%
36%
28%
26%
35%
Net Profit
10
8
1
17
11
11
10
2
10
3
4
11
17
8
EPS (₹)
3.91
3.18
0.4
6.42
4.35
4.15
3.79
0.91
3.89
1.28
1.4
4.32
6.25
—

Sep 2026: from the results filed on 31 Oct 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
NEOGEN profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
84
100
110
161
239
306
336
487
686
691
778
862
926
Expenses
71
86
90
132
196
248
272
401
575
581
641
725
772
Operating Profit
13
14
20
29
43
58
64
87
112
110
136
137
154
OPM %
15%
14%
18%
18%
18%
19%
19%
18%
16%
16%
18%
16%
17%
Other Income
1
0
0
1
1
0
1
1
5
8
−10
6
9
Interest
5
5
8
10
12
12
14
19
29
42
48
75
83
Depreciation
1
1
1
2
3
5
7
12
16
23
28
28
30
PBT
8
8
12
17
29
41
44
57
71
53
50
41
50
Tax %
37%
39%
33%
37%
28%
30%
29%
22%
30%
32%
31%
30%
—
Net Profit
5
5
8
11
21
29
31
45
50
36
35
29
36
EPS (₹)
11.31
2.59
3.84
5.49
10.43
12.28
13.43
17.9
20.04
13.51
13.2
10.9
13.25
Div. Payout %
18%
17%
0%
18%
14%
16%
17%
15%
15%
15%
8%
18%
—

Balance Sheet

₹ Cr
NEOGEN balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
20
20
20
20
23
23
25
25
26
26
26
Reserves
19
8
22
30
50
133
160
414
458
734
763
790
Borrowings
24
26
69
82
120
137
222
229
370
409
597
1,395
Other Liabilities
21
26
41
48
56
61
87
131
202
292
361
691
Total Liabilities
69
80
152
180
246
355
492
799
1,054
1,461
1,747
2,902
Fixed Assets
13
17
56
67
83
111
127
285
347
496
404
475
CWIP
0
1
1
1
0
3
115
11
36
109
156
857
Investments
0
0
0
0
1
1
1
82
77
0
0
0
Other Assets
55
62
94
112
163
241
250
422
594
856
1,187
1,570
Total Assets
69
80
152
180
246
355
492
799
1,054
1,461
1,747
2,902

Cash Flow

₹ Cr
NEOGEN cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
9
9
0
12
−4
−35
84
1
−30
−29
196
−231
Investing
−2
−4
−33
−13
−20
−29
−135
−146
−94
−216
−317
−410
Financing
−6
−4
33
0
24
63
51
188
100
237
113
642
Net Cash Flow
1
0
1
−1
0
−1
0
44
−25
−8
−8
0
Free Cash Flow
7
4
−33
−1
−24
−63
−51
−65
−134
−332
−121
−647
CFO/OP
89
83
21
55
4
−38
146
13
−17
−18
153
−154

Ratios

NEOGEN financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
78
58
107
94
93
90
85
82
94
149
94
161
Inventory Days
178
190
228
192
188
257
211
258
275
365
267
445
Days Payable
120
130
177
141
111
71
122
131
147
138
227
346
Cash Conversion Cycle
136
117
158
145
169
276
174
209
223
376
134
260
Working Capital Days
140
126
174
48
63
95
66
111
79
129
123
85
ROCE %
27%
26%
23%
23%
26%
22%
17%
14%
13%
9%
9%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Neogen Chemicals insights

62 extracted metrics across FY04–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 48.31%
  • DIIs 23.48%
  • Public 18.39%
  • Others 5.68%
  • FIIs 4.14%

23.00% of promoter holding pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Neogen Chemicals

What does Neogen Chemicals Ltd do?
Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries.
Where is Neogen Chemicals Ltd (NEOGEN) listed?
Neogen Chemicals Ltd trades as NEOGEN on the NSE and under code 542665 on the BSE.
Which sector does Neogen Chemicals Ltd belong to?
Neogen Chemicals Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Neogen Chemicals Ltd?
Neogen Chemicals Ltd trades at a PE ratio of 171.59 as of 4 Nov 2026, on earnings per share of ₹13.25, against a book value of ₹525.1 per share.
What is the 52-week high and low of Neogen Chemicals Ltd?
Over the last 52 weeks Neogen Chemicals Ltd has traded between ₹966.7 and ₹2,785 as of 4 Nov 2026.
Does Neogen Chemicals Ltd pay dividends?
Neogen Chemicals Ltd has a dividend yield of 0.05%.
What is the Return on Equity (ROE) of Neogen Chemicals Ltd?
Neogen Chemicals Ltd reported a return on equity of 3.58%. Its debt-to-equity ratio is 1.71.

Company Information

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries.

Website neogenchem.com
CEO Dr. Harin Haridas Kanani Ph.D.
Employees 779
Listed 8 May 2019
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NEOGEN.md for Neogen Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month